GO:1990380 K48-linked deubiquitinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1990380 defines K48-linked deubiquitinase activity, the hydrolysis of a ubiquitin unit from a substrate linked via Lys48 of ubiquitin.
• This activity directly opposes K48-linked polyubiquitination, a canonical signal for proteasomal degradation.
• Key enzymes include OTUD5, USP33, OTUD6A, USP11, USP7, USP22, USP5, and USP8, each with distinct substrate specificities [1-8].
• Dysregulation of K48-linked deubiquitinases contributes to cancer, neurodegeneration, inflammation, and metabolic disease [1-8].
• CRISPR knockout, point-mutation, knock-in, and overexpression models are essential to dissect substrate-specific functions [2,5,7].
• EDITGENE provides end-to-end CRISPR services and bioinformatics to accelerate K48-linked deubiquitinase research.
Description
K48-linked deubiquitinase activity (GO:1990380) is a molecular function that removes ubiquitin from proteins modified with Lys48-linked ubiquitin chains. This activity is critical because K48-linked polyubiquitination typically targets proteins for proteasomal degradation, and its reversal by deubiquitinases (DUBs) stabilizes key regulatory proteins. Researchers study this term to understand how cells control protein half-life, signaling thresholds, and stress responses. The importance of K48-linked deubiquitinases spans cancer, neurodegeneration, inflammation, and metabolic disorders, making them attractive therapeutic targets [4-8]. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:1990380, its mechanisms, key genes, and experimental approaches.
K48-linked deubiquitinase activity At A Glance
| GO ID | GO:1990380 |
|---|---|
| GO term | K48-linked deubiquitinase activity |
| Ontology | molecular_function |
| Synonym | K48-specific deubiquitinase activity; K48-specific deubiquitinating activity; Lys48-specific deubiquitinase activity |
| Major function | Hydrolysis of ubiquitin from K48-linked ubiquitinated proteins |
| Substrate specificity | K48-linked polyubiquitin chains |
| Biological context | Protein stability, proteasomal degradation, signaling |
| Representative enzymes | OTUD5, USP33, OTUD6A, USP11, USP7, USP22, USP5, USP8 |
What Is GO:1990380?
K48-linked deubiquitinase activity (GO:1990380) is defined as the hydrolysis of a ubiquitin unit from a ubiquitinated protein linked via the Lys48 residue of ubiquitin. In other words, it is an enzymatic activity that cleaves the isopeptide bond between the C-terminal glycine of one ubiquitin and the epsilon-amino group of Lys48 of another ubiquitin, thereby disassembling K48-linked polyubiquitin chains. This activity is specific to K48 linkages and is distinct from DUBs that recognize other linkage types.
Why Is K48-linked deubiquitinase activity Important in Cell Biology?
K48-linked deubiquitinase activity is essential for maintaining protein homeostasis by counteracting K48-linked polyubiquitination, which is the primary signal for proteasomal degradation. By removing these chains, DUBs stabilize substrates involved in cell cycle, apoptosis, DNA repair, and immune signaling [3,5]. Dysregulation of this activity can lead to accumulation of oncoproteins or loss of tumor suppressors, contributing to cancer and other diseases [6-8]. Therefore, understanding GO:1990380 is crucial for developing targeted therapies and for interpreting ubiquitin signaling in health and disease.
• Regulates protein stability by reversing K48-linked polyubiquitination.
• Controls proteasomal degradation of key signaling molecules.
• Modulates cell survival and apoptosis in cancer [5,6].
• Influences immune and inflammatory responses [3,8].
• Impacts neurodegeneration by affecting protein aggregation.
• Plays a role in metabolic reprogramming in cancer.
• Determines sensitivity to ferroptosis in ischemia/reperfusion injury.
• Provides potential drug targets for cancer therapy [4,5].
• Essential for mitophagy and mitochondrial quality control.
• Contributes to intestinal homeostasis and colitis.
Molecular Mechanism of K48-linked deubiquitinase activity
Substrate Recognition and Binding
In simple terms: The enzyme first grabs onto the ubiquitin chain attached to a target protein.
K48-linked deubiquitinases recognize their substrates through specific domains that bind to K48-linked polyubiquitin chains. For example, the non-catalytic UBL2 domain of USP11 directs the enzyme toward K48-linked chains, ensuring linkage specificity. Similarly, USP33 interacts with PRKN/parkin to deubiquitinate it, antagonizing mitophagy. This step is critical for selectivity and is often regulated by accessory domains or interacting partners [1,3].
Catalytic Hydrolysis of the Isopeptide Bond
In simple terms: The enzyme cuts the bond that holds ubiquitin to the target protein.
The catalytic core of DUBs, typically a cysteine protease or metalloprotease domain, hydrolyzes the isopeptide bond between the C-terminal glycine of ubiquitin and Lys48 of the substrate or the next ubiquitin in the chain [1,4]. This reaction releases free ubiquitin and reduces the chain length, effectively rescuing the substrate from degradation. The catalytic efficiency and specificity depend on the enzyme's active site architecture and conformational changes upon substrate binding.
Regulation by Interacting Proteins and Post-translational Modifications
In simple terms: Other proteins and chemical tags can turn the enzyme on or off.
K48-linked deubiquitinase activity is regulated by interacting proteins and post-translational modifications. For instance, OTUD5 protects against ferroptosis by deubiquitinating specific substrates, and its activity can be modulated by cellular stress. OTUD6A in macrophages deubiquitinates NLRP3, promoting inflammation, and its expression is induced by inflammatory stimuli. USP7 deubiquitinates KRAS, and its activity is essential for KRAS stability and downstream signaling. These examples highlight the layers of regulation that fine-tune DUB activity in response to cellular cues.
Linkage Specificity and Chain Editing
In simple terms: The enzyme only cuts K48-linked chains, not other types.
Linkage specificity is a hallmark of K48-linked deubiquitinases. USP11, for example, is directed toward K48-linked chains by its UBL2 domain, while other DUBs may prefer K63 or linear chains. This specificity ensures that only K48-linked signals are reversed, preserving other ubiquitin-dependent processes. Some DUBs can also edit chains by trimming them to monoubiquitin, further diversifying the signaling outcome.
Downstream Consequences for Substrate Fate
In simple terms: Removing the chain saves the protein from destruction or changes its function.
Deubiquitination of K48-linked chains typically prevents proteasomal degradation, leading to substrate stabilization [2,5]. For example, USP22 stabilizes PPARγ, promoting lipid accumulation in hepatocellular carcinoma. USP5 stabilizes c-Myc, reprogramming glucose metabolism. In contrast, some DUBs may also regulate non-degradative outcomes, such as altered localization or activity. The ultimate fate depends on the substrate and cellular context.
Key Genes Involved in GO:1990380 K48-linked deubiquitinase activity
The following genes encode enzymes with demonstrated K48-linked deubiquitinase activity or are directly involved in this function, as supported by verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| OTUD5 | Deubiquitinates substrates to protect against ferroptosis | Myocardial ischemia/reperfusion injury |
| USP33 | Deubiquitinates PRKN/parkin, antagonizes mitophagy | Neurodegeneration, mitophagy |
| OTUD6A | Deubiquitinates NLRP3 in macrophages | Intestinal inflammation, colitis |
| USP11 | K48-linked deubiquitinase directed by UBL2 domain | Linkage specificity, cancer |
| USP7 | Deubiquitinates KRAS, promotes NSCLC | Non-small cell lung cancer |
| USP22 | Stabilizes PPARγ, regulates lipidome | Hepatocellular carcinoma |
| USP5 | Stabilizes c-Myc, reprograms glucose metabolism | Hepatocellular carcinoma |
| USP8 | Inhibition reshapes inflamed tumor microenvironment | Cancer immunotherapy |
| PRKN/parkin | Substrate of USP33, E3 ubiquitin ligase | Mitophagy, Parkinson's disease |
| NLRP3 | Substrate of OTUD6A, inflammasome sensor | Inflammation, colitis |
| KRAS | Substrate of USP7, oncogenic GTPase | Lung cancer |
| PPARγ | Substrate of USP22, nuclear receptor | Lipid metabolism, HCC |
| c-Myc | Substrate of USP5, transcription factor | Glucose metabolism, HCC |
| 4-HNE | Lipid peroxidation product, triggers ferroptosis | Oxidative stress, ischemia |
How Is K48-linked deubiquitinase activity Regulated?
K48-linked deubiquitinase activity is regulated at multiple levels. Expression of DUBs can be induced by stress or inflammatory signals, as seen with OTUD6A in macrophages. Post-translational modifications, such as phosphorylation or ubiquitination of the DUB itself, can modulate activity. Interacting proteins can direct substrate specificity; for example, USP33 binds PRKN to regulate mitophagy. Additionally, the availability of K48-linked substrates and the cellular redox state influence DUB function. These regulatory layers ensure precise control of protein stability in response to environmental cues.
K48-linked deubiquitinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| USP7 | Non-small cell lung cancer | KRAS mutant lung cancer cell lines and xenografts |
| USP22 | Hepatocellular carcinoma | HCC cell lines with PPARγ stabilization |
| USP5 | Hepatocellular carcinoma | c-Myc-driven HCC models |
| OTUD6A | Colitis and intestinal inflammation | Macrophage-specific knockout mice |
| OTUD5 | Myocardial ischemia/reperfusion injury | Cardiomyocyte-specific knockout or overexpression |
Cancer
K48-linked deubiquitinases are frequently dysregulated in cancer. USP7 deubiquitinates KRAS, promoting non-small cell lung cancer growth. USP22 stabilizes PPARγ, enhancing lipid accumulation in hepatocellular carcinoma. USP5 stabilizes c-Myc, reprogramming glucose metabolism to support tumor progression. USP8 inhibition reshapes the tumor microenvironment and potentiates immunotherapy. These findings highlight DUBs as potential therapeutic targets.
Neurodegeneration
USP33 deubiquitinates PRKN/parkin, antagonizing its role in mitophagy. Since parkin mutations are linked to Parkinson's disease, modulation of K48-linked deubiquitinase activity may affect neuronal survival. This suggests that DUBs could be targeted to enhance mitophagy and clear damaged mitochondria in neurodegenerative conditions.
Inflammation and Colitis
OTUD6A in macrophages deubiquitinates NLRP3, promoting inflammasome activation and intestinal inflammation. This implicates K48-linked deubiquitinase activity in the pathogenesis of colitis and other inflammatory diseases. Targeting OTUD6A may offer a strategy to dampen excessive inflammation.
Ischemia/Reperfusion Injury
OTUD5 protects against 4-HNE-triggered ferroptosis in myocardial ischemia/reperfusion injury. By deubiquitinating key substrates, OTUD5 maintains cellular redox balance and prevents ferroptotic cell death. This positions K48-linked deubiquitinases as potential protectors in cardiovascular disease.
From K48-linked deubiquitinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of DUB affect substrate stability? | CRISPR knockout cell lines [2,5] |
| Does a point mutation in the catalytic domain abolish activity? | Point-mutation knock-in via CRISPR |
| Does tagging the endogenous DUB alter localization? | Knock-in of fluorescent or epitope tag |
| Does overexpression mimic disease phenotype? | Doxycycline-inducible overexpression [6,7] |
| Which substrates are deubiquitinated? | Proteomics with ubiquitin remnant antibodies |
| Does DUB inhibition synergize with immunotherapy? | Syngeneic mouse tumor models |
How to Study the K48-linked deubiquitinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ubiquitin chain restriction | Linkage specificity of DUB | Confirm K48-linked activity |
| Di-glycine remnant profiling | Global ubiquitination sites | Identify substrates [1,3] |
| CRISPR knockout screen | Genes required for a phenotype | Discover DUBs in ferroptosis |
| Co-immunoprecipitation | Protein-protein interactions | Validate DUB-substrate binding |
| Live-cell imaging | Substrate stability and localization | Track deubiquitination in real time |
| Western blot | Protein levels and ubiquitination | Assess substrate stabilization [5,6] |
| RNA-seq | Transcriptional changes | Measure downstream effects |
| Mass spectrometry | Protein interactions and modifications | Map DUB complexes |
Ubiquitin Chain Restriction Analysis
This method uses linkage-specific antibodies or mass spectrometry to determine whether a DUB cleaves K48-linked chains. It is essential for confirming GO:1990380 activity and distinguishing it from other DUB activities.
Proteomics and Ubiquitin Remnant Profiling
Di-glycine remnant profiling identifies ubiquitinated substrates and can reveal changes in K48-linked ubiquitination upon DUB manipulation. This approach helps map substrate specificity and downstream effects [1,3].
CRISPR Screens
Genome-wide CRISPR knockout screens can identify DUBs that regulate specific pathways, such as ferroptosis or immune signaling. Hits can be validated with targeted assays [1,8].
Live-cell Imaging
Fluorescently tagged DUBs and substrates allow real-time visualization of deubiquitination and substrate stabilization. This method provides spatial and temporal insights into DUB function.
How CRISPR Can Be Used to Study GO:1990380 K48-linked deubiquitinase activity
Knockout
CRISPR knockout of a DUB gene eliminates its K48-linked deubiquitinase activity, allowing researchers to observe substrate accumulation or degradation. For example, USP33 knockout enhances parkin ubiquitination and mitophagy. Knockout models are essential for loss-of-function studies.
Point Mutation
Introducing point mutations in the catalytic cysteine or other key residues abolishes enzymatic activity without affecting protein expression. This helps distinguish catalytic from scaffolding functions. For instance, mutating the catalytic domain of USP11 can confirm its role in K48-linked chain cleavage.
Knock-in
Knock-in of epitope tags or fluorescent proteins at the endogenous locus enables tracking of DUB expression and localization. This approach preserves native regulation and can reveal dynamic changes during stress.
Overexpression
Overexpression of a DUB can stabilize its substrates and mimic disease states. For example, USP22 overexpression increases PPARγ levels and lipid accumulation in HCC cells. Overexpression models are useful for gain-of-function studies and drug testing.
How EDITGENE Supports K48-linked deubiquitinase activity Research
Researchers studying K48-linked deubiquitinase activity-related genes often need to determine whether a candidate gene is causally involved in a specific pathway or disease. EDITGENE provides comprehensive CRISPR services to generate precisely engineered cell models, enabling rigorous functional validation.
Contact EDITGENE today to design your custom CRISPR model for K48-linked deubiquitinase activity research.
Frequently Asked Questions About K48-linked deubiquitinase activity
What is K48-linked deubiquitinase activity?
It is the enzymatic removal of ubiquitin from proteins modified with K48-linked ubiquitin chains, as defined by GO:1990380.
What genes are involved in K48-linked deubiquitinase activity?
Key genes include OTUD5, USP33, OTUD6A, USP11, USP7, USP22, USP5, and USP8 [1-8].
How does K48-linked deubiquitination affect protein stability?
It prevents proteasomal degradation by removing the K48-linked chain, thereby stabilizing the substrate [2,5].
What diseases are associated with K48-linked deubiquitinases?
They are linked to cancer, neurodegeneration, inflammation, and ischemia/reperfusion injury [1-8].
What methods are used to study K48-linked deubiquitinase activity?
Common methods include ubiquitin chain restriction assays, proteomics, CRISPR screens, and live-cell imaging [1,4].
Can CRISPR knockout be used to study K48-linked deubiquitinases?
Yes, knockout cell lines eliminate the enzyme and reveal substrate accumulation or loss [2,5].
What is the difference between K48 and K63-linked deubiquitination?
K48-linked chains typically signal degradation, while K63-linked chains regulate signaling; DUBs show linkage specificity.
Which DUB is linked to ferroptosis?
OTUD5 protects against ferroptosis by deubiquitinating substrates in myocardial ischemia/reperfusion injury.
How is USP7 involved in cancer?
USP7 deubiquitinates KRAS, promoting non-small cell lung cancer growth.
What services does EDITGENE offer for DUB research?
EDITGENE provides CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services.
Conclusion
K48-linked deubiquitinase activity (GO:1990380) is a fundamental molecular function that controls protein stability by reversing K48-linked polyubiquitination. Its dysregulation contributes to cancer, neurodegeneration, inflammation, and metabolic diseases. Key enzymes such as OTUD5, USP33, OTUD6A, USP11, USP7, USP22, USP5, and USP8 have been characterized in diverse biological contexts [1-8]. Understanding their mechanisms and substrates requires robust experimental models, including CRISPR knockout, point mutation, knock-in, and overexpression. EDITGENE offers comprehensive services to support these studies and accelerate therapeutic development.
References
- 1. Liu L et al.. 2023. Deubiquitinase OTUD5 as a Novel Protector against 4-HNE-Triggered Ferroptosis in Myocardial Ischemia/Reperfusion Injury.. Adv Sci (Weinh) 10(28):e2301852 PMID: 37552043
- 2. Niu K et al.. 2020. USP33 deubiquitinates PRKN/parkin and antagonizes its role in mitophagy.. Autophagy 16(4):724-734 PMID: 31432739
- 3. Liu X et al.. 2023. Deubiquitinase OTUD6A in macrophages promotes intestinal inflammation and colitis via deubiquitination of NLRP3.. Cell Death Differ 30(6):1457-1471 PMID: 36932155
- 4. Lee SR et al.. 2025. Non-catalytic UBL2 domain directs deubiquitinase USP11 toward K48-linked polyubiquitin chains.. J Biol Chem 301(12):110924 PMID: 41207628
- 5. Huang B et al.. 2024. USP7 deubiquitinates KRAS and promotes non-small cell lung cancer.. Cell Rep 43(11):114917 PMID: 39499616
- 6. Ning Z et al.. 2022. USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma.. Nat Commun 13(1):2187 PMID: 35449157
- 7. Xia P et al.. 2023. METTL5 stabilizes c-Myc by facilitating USP5 translation to reprogram glucose metabolism and promote hepatocellular carcinoma progression.. Cancer Commun (Lond) 43(3):338-364 PMID: 36602428
- 8. Xiong W et al.. 2022. USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy.. Nat Commun 13(1):1700 PMID: 35361799
